Press Release
Press Release
Press Contacts: Erik Cummins, Matt Hyams, Taina Rosa, Olivia Meyer
06.17.26
Pillsbury advised TJM Labs, a leader in AI automation for pharmacy operations, on its acquisition of Pharmesol, further enhancing TJM’s integrated pharmacy AI platform and expanding its capabilities across workflow automation, patient communication and voice-enabled interactions.
TJM’s platform supports more than 400 pharmacies and facilitates the processing of over 300,000 prescriptions daily, helping pharmacy organizations reduce administrative burden, improve operational efficiency and scale operations. The addition of Pharmesol strengthens TJM’s ability to automate inbound and outbound communications with patients, provider clinics and pharmacy benefit managers, or PBMs.
The acquisition comes as TJM continues to broaden its platform to serve retail, long-term care, specialty, compounding and enterprise pharmacy organizations seeking scalable ways to modernize operations.
Click here to learn more.
The Pillsbury deal team was led by Corporate partner Steven Green and included associates Kit Ryan and Krisha Patel and senior legal analyst Rory O’Neill; Tax partners Julie Divola and Nora Burke; Technology Transactions partner Daphne Higgs; and Executive Compensation & Benefits partner Colleen Lamarre.